Glen Denmer Santok

About

Dr. Glen Denmer Santok is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive robotic surgery for prostate and kidney cancers. His major contributions focus on refining the Retzius-sparing approach to robot-assisted radical prostatectomy (RARP), demonstrating that this technique significantly lowers the risk of postoperative inguinal hernia development (46 citations) and yields excellent outcomes regardless of prostate gland size (31 citations). Dr. Santok has also pioneered combined procedures, such as simultaneous Retzius-sparing RARP and partial nephrectomy (14 citations), showcasing the versatility of robotic platforms. His research extends to renal oncology, where he has proven that robot-assisted partial nephrectomy provides durable long-term results for complex cystic tumors (16 citations) and explored off-clamp techniques to optimize renal function recovery. With a cumulative impact of nearly 200 citations, Dr. Santok’s work has been instrumental in standardizing surgical training through proctorship models (30 citations) and in refining risk stratification for prostate cancer patients, notably identifying PSA levels of 10–20 ng/mL as a predictor of Gleason score upgrading (19 citations). His stratified analysis of 800 Asian patients with a median 64-month follow-up (9 citations) remains one of the largest Asian RARP series, cementing his role as a key figure in global robotic urology.

Research Focus

Key Achievements

Top Papers

1. 1
   Anatomical Retzius-space preservation is associated with lower incidence of postoperative inguinal hernia development after robot-assisted radical prostatectomy

   46 citations · 2017
2. 2
   Perioperative and short‐term outcomes of Retzius‐sparing robot‐assisted laparoscopic radical prostatectomy stratified by gland size

   31 citations · 2016
3. 3
   Proctorship and mentoring: Its backbone and application in robotic surgery

   30 citations · 2016
4. 4
   Prostate-specific antigen 10–20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6

   19 citations · 2017
5. 5
   Robot‐assisted partial nephrectomy confers excellent long‐term outcomes for the treatment of complex cystic renal tumors: Median follow up of 58 months

   16 citations · 2016
6. 6
   Simultaneous Retzius-sparing robot-assisted radical prostatectomy and partial nephrectomy

   14 citations · 2016
7. 7
   Stratified analysis of 800 Asian patients after robot‐assisted radical prostatectomy with a median 64 months of follow up

   9 citations · 2016
8. 8
   Retzius-sparing robot-assisted radical prostatectomy is safe for patients with prior transurethral prostate surgery

   6 citations · 2018
9. 9
   Off-Clamp Robot-Assisted Partial Nephrectomy: How Far Shall We Proceed?

   6 citations · 2017
10. 10
    Estimated glomerular filtration rate's time to nadir after robot‐assisted partial nephrectomy: Predictors and clinical significance on renal functional recovery

    3 citations · 2018

Key Collaborators

Contact & Links